跳至主要内容
临床试验/NCT03312478
NCT03312478已完成4 期

To Evaluate the Association Between Type 1 Diabetes Mellitus (T1DM) in Offspring With Positive Parental History of Diabetes

Sanofi1 个研究点 分布在 1 个国家目标入组 375 人开始时间: 2017年10月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Sanofi
入组人数
375
试验地点
1
主要终点
Odds of Type 1 Diabetes Mellitus child having a diabetic parent

研究概览

简要总结

Primary Objective:

To measure the association between a parental history of diabetes and the odds of an offspring being Type 1 diabetics.

Secondary Objectives:

  • To document the profile of Type 1 diabetes patients.
  • To document the glycemic parameters (Fasting blood glucose [FBG] and glycosylated hemoglobin [HbA1c]) of Type 1 diabetes.
  • To capture the current therapeutic management.

详细描述

The overall duration of this study is expected to be 12 months. The recruitment period for a given center will be four months following site initiation of that center. telephonic follow-up for all the patients shall be conducted after 15 days ± 5 days.

*Each patient (cases as well as controls) will be required to undergo laboratory tests for insulin autoantibodies and hemoglobin A1c tests. Both the tests will be conducted through centralized laboratories for all recruited patients.

Since the result of insulin auto-antibodies test is one of the inclusion criteria, it is mandatory for all patients to undergo this test, and detailed information for the same has been included in the informed consent form.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
2 Years 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Case

Other

Known cases of type 1 diabetes mellitus as described in the inclusion criteria for cases

干预措施: Blood draw for insulin auto-anti body tests* (Drug)

Control

Other

Age-matched non-diabetic controls as described in the inclusion criteria for controls

干预措施: Blood draw for insulin auto-anti body tests* (Drug)

结局指标

主要结局

Odds of Type 1 Diabetes Mellitus child having a diabetic parent

时间窗: 12 months

Odds ratio will be used to calculate and measure disease frequency from dichotomous categorical variables

次要结局

  • Characterization of this population by gender(12 months)
  • Means of HbA1c in Type 1 diabetes mellitus (T1DM) patients(12 months)
  • Means of fasting blood glucose (FBG) in T1DM patients(12 months)
  • Standard deviation of FBG in T1DM patients(12 months)
  • Mean duration of diabetes in parent(12 months)
  • Characterization of frequency of consultation(12 months)
  • Characterization of diabetes education(12 months)
  • Standard deviation of HbA1c in T1DM patients(12 months)
  • Characterization of family history of diabetes(12 months)
  • Characterization of this population by age(12 months)
  • Characterization of this population by socio-economic profile(12 months)
  • Distribution of prescribed therapies by type of insulin to T1DM patients(12 months)
  • Duration of diabetes in parent(12 months)

研究者

发起方
Sanofi
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验